Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Memphasys Ltd ( (AU:MEM) ) has issued an announcement.
Memphasys Limited has announced a change in its external auditors, appointing BDO Audit Pty Ltd following the resignation of Pitcher Partners. This decision comes as part of a corporate review by the Board, aligning with the company’s strategic move towards the international commercialization of its Felix™ Device.
More about Memphasys Ltd
Memphasys Limited is a biotechnology company specializing in advanced reproductive biotechnology. They develop medical devices, diagnostics, and proprietary media for both human and animal applications. Their flagship technologies include the Felix™ and RoXsta™ Systems, aimed at enhancing fertility outcomes globally.
Average Trading Volume: 52,211,380
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$9.92M
See more data about MEM stock on TipRanks’ Stock Analysis page.